| Title: | Remission is maintained after switch from dose-optimised intravenous treatment to subcutaneous treatment with vedolizumab in inflammatory bowel disease |
|---|
| Authors: | ID Pintar, Špela (Author)
ID Hanžel, Jurij (Author)
ID Drobne, David (Author)
ID Koželj, Matic (Author)
ID Kurent, Tina (Author)
ID Smrekar, Nataša (Author)
ID Novak, Gregor (Author) |
|---|
| Files: |  PDF - Presentation file, download (630,74 KB)
MD5: 8CCCE3BD91032E37EF19EF5A75287A4B
 URL - Source URL, visit https://www.mdpi.com/1648-9144/60/2/296
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  UKC LJ - Ljubljana University Medical Centre
|
|---|
| Keywords: | inflammatory bowel disease, Crohn’s disease, ulcerative colitis, vedolizumab, subcutaneous formulation |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2024 |
|---|
| Number of pages: | str. 1-12 |
|---|
| Numbering: | Vol. 60, iss. 2, [article no.] 296 |
|---|
| PID: | 20.500.12556/DiRROS-30053  |
|---|
| UDC: | 616.3 |
|---|
| ISSN on article: | 1648-9144 |
|---|
| DOI: | 10.3390/medicina60020296 |
|---|
| COBISS.SI-ID: | 186507267 |
|---|
| Note: | Nasl. z nasl. zaslona;
Opis z dne 22. 2. 2024;
|
|---|
| Publication date in DiRROS: | 12.06.2026 |
|---|
| Views: | 46 |
|---|
| Downloads: | 32 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
